Cholesterol Efflux Capacity, Macrophage Reverse Cholesterol Transport, and Cardioprotective HDL

Documenti analoghi

• Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
  di: Vaisar, Tomáš, et al.
  Pubblicazione: (2015)
• Niacin therapy increases HDL particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
  di: Ronsein, Graziella E., et al.
  Pubblicazione: (2015)
• Small HDL Promotes Cholesterol Efflux by the ABCA1 Pathway in Macrophages: Implications for Therapies Targeted to HDL
  di: Heinecke, Jay W.
  Pubblicazione: (2015)
• Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause
  di: El Khoudary, Samar R., et al.
  Pubblicazione: (2016)
• Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport
  di: Kuwano, Takashi, et al.
  Pubblicazione: (2017)